{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:44:45Z","timestamp":1781160285403,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-017-1305-2","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T11:23:53Z","timestamp":1516620233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Chengguang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"issue":"6","key":"1305_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5694\/mja12.11357","volume":"198","author":"SR Cole","year":"2013","unstructured":"Cole SR, Tucker GR, Osborne JM, Byrne SE, Bampton PA, Fraser RJ, Young GP. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust. 2013;198(6):327\u201330.","journal-title":"Med J Aust"},{"key":"1305_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics. CA Cancer J Clin. 2014;64:104\u201317.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.7314\/APJCP.2015.16.6.2431","volume":"16","author":"D Roder","year":"2015","unstructured":"Roder D, Karapetis CS, Wattchow D, Moore J, Singhal N, Joshi R, Keefe D, Fusco K, Powell K, Eckert M, Price TJ. Colorectal cancer treatment and survival: the experience of major public hospitals in South Australia over three decades. Asian Pac J Cancer Prev. 2015;16(6):2431\u201340.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"19","key":"1305_CR4","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Punt CJ, Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progress ion-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(19):3213\u201321.","journal-title":"J Clin Oncol"},{"issue":"19","key":"1305_CR5","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","volume":"14","author":"JS de Bono","year":"2008","unstructured":"de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302\u20139.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1305_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781\u201391.","journal-title":"N Engl J Med"},{"issue":"30","key":"1305_CR7","doi-asserted-by":"publisher","first-page":"10296","DOI":"10.3748\/wjg.v20.i30.10296","volume":"20","author":"U Bork","year":"2014","unstructured":"Bork U, Gr\u00fctzmann R, Rahbari NN, Sch\u00f6lch S, Distler M, Reissfelder C, Koch M, Weitz J. Prognostic relevance of minimal residual disease in colorectal cancer. World J Gastroenterol. 2014;20(30):10296\u2013304.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"1305_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/bjc.2015.88","volume":"112","author":"U Bork","year":"2015","unstructured":"Bork U, Rahbari NN, Sch\u00f6lch S, Reissfelder C, Kahlert C, B\u00fcchler MW, Weitz J, Koch M. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer. 2015;112(8):1306\u201313.","journal-title":"Br J Cancer"},{"key":"1305_CR9","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.2147\/OTT.S115268","volume":"9","author":"E Souza","year":"2016","unstructured":"Souza E, Silva V, Chinen LT, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino AL, de Mello CA, Alves VS, Fanelli MF. Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells. Onco Targets Ther. 2016;9:7503\u201313.","journal-title":"Onco Targets Ther"},{"key":"1305_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1373\/clinchem.2011.175570","volume":"58","author":"K Pantel","year":"2012","unstructured":"Pantel K, Pantel K, Den\u00e8ve E, Nocca D, Coffy A, Vendrell JP, Maudelonde T, Riethdorf S, Alix-Panabi\u00e8res C. Circulating epithelial cells in patients with benign colon diseases. Clin Chem. 2012;58:936\u201340.","journal-title":"Clin Chem"},{"key":"1305_CR11","doi-asserted-by":"publisher","first-page":"24517","DOI":"10.1038\/srep24517","volume":"6","author":"W-S Tsai","year":"2016","unstructured":"Tsai W-S, Chen J-S, Shao H-J, J-C W, Lai JM, Lu S-H, Hung T-F, Chiu Y-C, You J-F, Hsieh P-S, Yeh C-Y, Hung H-Y, Chiang S-F, Lin G-P, Tang R-P, Chang Y-C. Circulating tumor cell count correlates with colorectal neoplasm progression and is a prognostic marker for distant metastasis in non-metastatic patients. Sci Rep. 2016;6:24517.","journal-title":"Sci Rep"},{"issue":"7","key":"1305_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gutjnl-2017-314005","volume":"66","author":"JE East","year":"2017","unstructured":"East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, Leedham SJ, Phull PS, Rutter MD, Shepherd NA, Tomlinson I, Rees CJ. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66(7):1181\u201396.","journal-title":"Gut"},{"key":"1305_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/1471-2407-12-178","volume":"12","author":"TM Gorges","year":"2012","unstructured":"Gorges TM, Tinhofer I, Drosch M, R\u00f6se L, Zollner TM, Krahn T, von Ahsen O. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer. 2012;12:178.","journal-title":"BMC Cancer"},{"issue":"Suppl 1","key":"1305_CR14","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.2119\/molmed.2015.00149","volume":"21","author":"JE Hardingham","year":"2015","unstructured":"Hardingham JE, Grover P, Winter M, Hewett PJ, Price TJ, Thierry B. Detection and clinical significance of circulating tumor cells in colorectal cancer-20 years of progress. Mol Med. 2015;21(Suppl 1):S25\u201331.","journal-title":"Mol Med"},{"issue":"1","key":"1305_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-016-0679-3","volume":"18","author":"S Kasimir-Bauer","year":"2016","unstructured":"Kasimir-Bauer S, Bittner AK, K\u00f6nig L, Reiter K, Keller T, Kimmig R, Hoffmann O. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy. Breast Cancer Res. 2016;18(1):20.","journal-title":"Breast Cancer Res"},{"key":"1305_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1186\/1471-2407-14-976","volume":"14","author":"X Huang","year":"2014","unstructured":"Huang X, Gao P, Song Y, Sun J, Chen X, Zhao J, Liu J, Xu H, Wang Z. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis. BMC Cancer. 2014;14:976.","journal-title":"BMC Cancer"},{"issue":"13","key":"1305_CR17","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.18632\/oncotarget.4037","volume":"6","author":"A Mitra","year":"2015","unstructured":"Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug- resistance. Oncotarget. 2015;6(13):10697\u2013711.","journal-title":"Oncotarget"},{"issue":"3","key":"1305_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jmoldx.2015.02.001","volume":"17","author":"B Gold","year":"2015","unstructured":"Gold B, Cankovic M, Furtado LV, Meier F, Gocke CD. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the Association for Molecular Pathology. J Mol Diagn. 2015;17(3):209\u201324.","journal-title":"J Mol Diagn"},{"key":"1305_CR19","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/bcr3395","volume":"15","author":"A Strati","year":"2013","unstructured":"Strati A, Kasimir-Bauer S, Markou A, Parisi C, Lianidou ES. Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer. Breast Cancer Res. 2013;15:R20.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"1305_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/cas.12868","volume":"107","author":"T Sawada","year":"2016","unstructured":"Sawada T, Watanabe M, Fujimura Y, Yagishita S, Shimoyama T, Maeda Y, Kanda S, Yunokawa M, Tamura K, Tamura T, Minami H, Koh Y, Koizumi F. Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells. Cancer Sci. 2016;107(3):307\u201314.","journal-title":"Cancer Sci"},{"issue":"3","key":"1305_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.7314\/APJCP.2016.17.3.939","volume":"17","author":"D El-Gayar","year":"2016","unstructured":"El-Gayar D, El-Abd N, Hassan N, Ali R. Increased free circulating DNA integrity index as a serum biomarker in patients with colorectal carcinoma. Asian Pac J Cancer Prev. 2016;17(3):939\u201344.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"1305_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201303698","volume":"7","author":"SA Joosse","year":"2015","unstructured":"Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7(1):1\u201311.","journal-title":"EMBO Mol Med"},{"issue":"47","key":"1305_CR23","doi-asserted-by":"publisher","first-page":"13259","DOI":"10.3748\/wjg.v21.i47.13259","volume":"21","author":"TT Li","year":"2015","unstructured":"Li TT, Liu H, Li FP, YF H, Mou TY, Lin T, Yu J, Zheng L, Li GX. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: relevance to therapy response. World J Gastroenterol. 2015;21(47):13259\u201367.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1305_CR24","doi-asserted-by":"publisher","first-page":"dju066","DOI":"10.1093\/jnci\/dju066","volume":"106","author":"B Rack","year":"2014","unstructured":"Rack B, Schindlbeck C, J\u00fcckstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W, SUCCESS Study Group. Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J Natl Cancer Inst. 2014;106(5):dju066.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1305_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/bjc.2012.595","volume":"108","author":"CY Lu","year":"2013","unstructured":"Lu CY, Tsai HL, Uen YH, Hu HM, Chen CW, Cheng TL, Lin SR, Wang JY. Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer. Br J Cancer. 2013;108(4):791\u20137.","journal-title":"Br J Cancer"},{"issue":"2","key":"1305_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.10.005","volume":"150","author":"G Parthasarathy","year":"2016","unstructured":"Parthasarathy G, Chen J, Chen X, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology. 2016;150(2):367\u201379.","journal-title":"Gastroenterology"},{"key":"1305_CR27","doi-asserted-by":"publisher","unstructured":"Rubio CA, Puppa G, de Petris G, et al. The third pathway of colorectal carcinogenesis. J Clin Pathol. 2018;71(1):7\u201311. \n                    https:\/\/doi.org\/10.1136\/jclinpath-2017-204660\n                    \n                  . Epub 2017 Jul 27.","DOI":"10.1136\/jclinpath-2017-204660"},{"issue":"1","key":"1305_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molmed.2016.11.004","volume":"23","author":"S Li","year":"2017","unstructured":"Li S, Konstantinov SR, Smits R, et al. Bacterial biofilms in colorectal cancer initiation and progression. Trends Mol Med. 2017;23(1):18\u201330.","journal-title":"Trends Mol Med"},{"key":"1305_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2006.12.014","volume":"253","author":"P Paterlini-Brechot","year":"2007","unstructured":"Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007;253:180\u2013204.","journal-title":"Cancer Lett"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-017-1305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T14:36:03Z","timestamp":1548254163000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-017-1305-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1186\/s12957-017-1305-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,22]]},"assertion":[{"value":"18 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried on after acquiring patients\u2019 consent and Tongren Hospital ethics committee approval and consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"13"}}